Moderna Inc reported $155.35B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Acorda Therapeutics ACOR:US $ 0.05B 0.01B
Agios Pharmaceuticals AGIO:US $ 2.72B 0.67B
Alexion Pharmaceuticals ALXN:US $ 33.78B 0.39B
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Arrowhead Research ARWR:US $ 6.51B 2.11B
Biogen BIIB:US $ 42.18B 9.96B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 0.87B
Esperion Therapeutics ESPR:US $ 0.34B 0.26B
Gilead Sciences GILD:US $ 87.58B 1.22B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Intercept Pharmaceuticals ICPT:US $ 0.49B 0.17B
IONIS PHARMACEUT IONS:US $ 4.73B 0.89B
Mirati Therapeutics MRTX:US $ 9.13B 0.82B
Puma Biotechnology PBYI:US $ 0.29B 0.08B
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Sangamo Biosciences SGMO:US $ 1.31B 0.41B
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 0.32B
United Therapeutics UTHR:US $ 8.29B 0.25B
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
YTE INCY:US $ 15.19B 3.31B